Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Expression Charted in the Brain Throughout Lifespan

By LabMedica International staff writers
Posted on 09 Nov 2011
The activation or expression of specific genes in the human genome is what makes each human and human tissue unique. More...
New findings have revealed that many gene expression changes that occur during fetal development are reversed immediately after birth.

Reversals of fetal expression changes are also seen again much later in life during normal aging of the brain. Moreover, the investigators, from the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA), the Lieber Institute for Brain Development (Baltimore, MD, USA), and the US National Institute of Mental Health (Bethesda, MD, USA) observed the reversal of fetal expression changes in Alzheimer’s disease findings reported in other studies. The researchers also found that gene expression change is fastest in human brain tissue during fetal development, slows down through childhood and adolescence, stabilizes in adulthood, and then speeds up again after age 50, with a definite redirection of expression changes before birth and in early adulthood. Their findings are published in the October 27, 2011, in the journal Nature.

Utilizing a variety of genomic analysis methods, the research team conducted genome-wide genetic (DNA) and gene expression (RNA) analyses of brain tissue samples from the prefrontal cortex. Tissue represented the various stages of the human lifespan. “We think that these coordinated changes in gene expression connecting fetal development with aging and neurodegeneration are central to how the genome constructs the human brain and how the brain ages,” said Carlo Colantuoni, PhD, one of the lead authors of the study and a former research associate with the department of biostatistics at the Johns Hopkins Bloomberg School of Public Health. Dr. Colantuoni recently joined the Lieber Institute for Brain Development on the Johns Hopkins Medical Campus.

The research also revealed that brain gene expression differences between genetically diverse individuals are no greater than the differences between individuals sharing many more genetic traits. “Our findings highlight the fact that current technologies and analysis methods can address the effects of individual genetic traits in isolation, but we have virtually no understanding of how our many millions of genetic traits work in concert with one another,” added Dr. Colantuoni.

Related Links:
Johns Hopkins Bloomberg School of Public Health
Lieber Institute for Brain Development
US National Institute of Mental Health



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.